FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4383270912> ?p ?o ?g. }

• W4383270912 endingPage "1919" @default.
• W4383270912 startingPage "1913" @default.
• W4383270912 abstract "Background: Immune-mediated diarrhea and colitis (IMDC) frequently develop after treatment with immune checkpoint inhibitors. C-reactive protein (CRP) is a serum inflammatory biomarker used to stratify and monitor disease severity in many inflammatory conditions. However, CRP level is not specific and is widely influenced by various factors non-specific to bowel inflammation. We aimed to study the utility of CRP as a predictor of disease severity and therapy response in IMDC. Methods: We performed a retrospective analysis of patients diagnosed with IMDC who had CRP measured at IMDC onset and after treatment with selective immunosuppressive therapy (SIT: infliximab and vedolizumab), between 01/2016 and 02/2022 at MD Anderson Cancer Center. Patient demographics, clinical characteristics, and IMDC data were collected and analyzed. Results: Our sample of 128 patients had a median age of 67 years; most were white (89.8%); and male (65.6%). Prior to development of IMDC, 15 (11.7%) were initially treated with anti-CTLA-4, 42 (32.8%) with anti-PD-1 or PD-L1, and 71 (55.5%) with a combination of both. We found higher CRP level was associated with higher CTCAE grade of clinical symptoms such as diarrhea (p=0.015), colitis (p=0.013), and endoscopic findings (p=0.016). While CRP levels decreased after IMDC treatment, there was no significant association between CRP levels with clinical remission, endoscopic remission or histologic remission. There also was no significant correlation between CRP level and recurrence of IMDC, or with fecal calprotectin levels. Conclusion: CRP level may be useful to assess initial severity of IMDC, including grade of diarrhea and colitis and degree of endoscopic inflammation. However, CRP is not a robust surrogate biomarker for assessing treatment response or disease recurrence. Despite the reduction of CRP levels observed following IMDC treatment, this finding might be nonspecific and potentially confounded by concurrent clinical factors, such as underlying malignancy, other inflammatory processes, and systemic anti-cancer therapy. Further studies of the role of CRP are warranted in patients with cancer and IMDC." @default.
• W4383270912 created "2023-07-06" @default.
• W4383270912 creator A5003027125 @default.
• W4383270912 creator A5020398369 @default.
• W4383270912 creator A5024460514 @default.
• W4383270912 creator A5026717218 @default.
• W4383270912 creator A5039057988 @default.
• W4383270912 creator A5039869596 @default.
• W4383270912 creator A5042372543 @default.
• W4383270912 creator A5042917768 @default.
• W4383270912 creator A5043077558 @default.
• W4383270912 creator A5057402683 @default.
• W4383270912 creator A5067541902 @default.
• W4383270912 creator A5071593155 @default.
• W4383270912 creator A5073007668 @default.
• W4383270912 creator A5080142532 @default.
• W4383270912 date "2023-01-01" @default.
• W4383270912 modified "2023-10-02" @default.
• W4383270912 title "Role of C-Reactive Protein in Predicting the Severity and Response of Immune-Mediated Diarrhea and Colitis in Patients with Cancer" @default.
• W4383270912 cites W1977455486 @default.
• W4383270912 cites W2036630215 @default.
• W4383270912 cites W2075309439 @default.
• W4383270912 cites W2090131432 @default.
• W4383270912 cites W2105857910 @default.
• W4383270912 cites W2123199917 @default.
• W4383270912 cites W2132853322 @default.
• W4383270912 cites W2142941022 @default.
• W4383270912 cites W2158926558 @default.
• W4383270912 cites W2522113323 @default.
• W4383270912 cites W2800213865 @default.
• W4383270912 cites W2905315040 @default.
• W4383270912 cites W2994015360 @default.
• W4383270912 cites W3025307725 @default.
• W4383270912 cites W3042026617 @default.
• W4383270912 cites W3049349821 @default.
• W4383270912 cites W3102226582 @default.
• W4383270912 cites W3112789381 @default.
• W4383270912 cites W3119143401 @default.
• W4383270912 cites W3126292443 @default.
• W4383270912 cites W3126366494 @default.
• W4383270912 cites W3147110368 @default.
• W4383270912 cites W3159374722 @default.
• W4383270912 cites W3198787950 @default.
• W4383270912 doi "https://doi.org/10.7150/jca.84261" @default.
• W4383270912 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37476185" @default.
• W4383270912 hasPublicationYear "2023" @default.
• W4383270912 type Work @default.
• W4383270912 citedByCount "0" @default.
• W4383270912 crossrefType "journal-article" @default.
• W4383270912 hasAuthorship W4383270912A5003027125 @default.
• W4383270912 hasAuthorship W4383270912A5020398369 @default.
• W4383270912 hasAuthorship W4383270912A5024460514 @default.
• W4383270912 hasAuthorship W4383270912A5026717218 @default.
• W4383270912 hasAuthorship W4383270912A5039057988 @default.
• W4383270912 hasAuthorship W4383270912A5039869596 @default.
• W4383270912 hasAuthorship W4383270912A5042372543 @default.
• W4383270912 hasAuthorship W4383270912A5042917768 @default.
• W4383270912 hasAuthorship W4383270912A5043077558 @default.
• W4383270912 hasAuthorship W4383270912A5057402683 @default.
• W4383270912 hasAuthorship W4383270912A5067541902 @default.
• W4383270912 hasAuthorship W4383270912A5071593155 @default.
• W4383270912 hasAuthorship W4383270912A5073007668 @default.
• W4383270912 hasAuthorship W4383270912A5080142532 @default.
• W4383270912 hasBestOaLocation W43832709121 @default.
• W4383270912 hasConcept C121608353 @default.
• W4383270912 hasConcept C126322002 @default.
• W4383270912 hasConcept C185592680 @default.
• W4383270912 hasConcept C203014093 @default.
• W4383270912 hasConcept C2775862500 @default.
• W4383270912 hasConcept C2776207728 @default.
• W4383270912 hasConcept C2776914184 @default.
• W4383270912 hasConcept C2777138892 @default.
• W4383270912 hasConcept C2778260677 @default.
• W4383270912 hasConcept C2778292693 @default.
• W4383270912 hasConcept C2779134260 @default.
• W4383270912 hasConcept C2779802037 @default.
• W4383270912 hasConcept C2780479503 @default.
• W4383270912 hasConcept C2781195455 @default.
• W4383270912 hasConcept C2781197716 @default.
• W4383270912 hasConcept C526805850 @default.
• W4383270912 hasConcept C55493867 @default.
• W4383270912 hasConcept C71924100 @default.
• W4383270912 hasConcept C90924648 @default.
• W4383270912 hasConceptScore W4383270912C121608353 @default.
• W4383270912 hasConceptScore W4383270912C126322002 @default.
• W4383270912 hasConceptScore W4383270912C185592680 @default.
• W4383270912 hasConceptScore W4383270912C203014093 @default.
• W4383270912 hasConceptScore W4383270912C2775862500 @default.
• W4383270912 hasConceptScore W4383270912C2776207728 @default.
• W4383270912 hasConceptScore W4383270912C2776914184 @default.
• W4383270912 hasConceptScore W4383270912C2777138892 @default.
• W4383270912 hasConceptScore W4383270912C2778260677 @default.
• W4383270912 hasConceptScore W4383270912C2778292693 @default.
• W4383270912 hasConceptScore W4383270912C2779134260 @default.
• W4383270912 hasConceptScore W4383270912C2779802037 @default.
• W4383270912 hasConceptScore W4383270912C2780479503 @default.
• W4383270912 hasConceptScore W4383270912C2781195455 @default.
• W4383270912 hasConceptScore W4383270912C2781197716 @default.

• next